Shogaol overcomes TRAIL resistance in colon cancer cells via inhibiting of survivin

Citations

WEB OF SCIENCE

32
Citations

SCOPUS

24

초록

In this study, we showed the ability of representative shogaol, which as a major component of ginger, to overcome TRAIL resistance by increasing apoptosis in colon cancer cells. Shogaol increased death receptor 5 (DR5) levels. Furthermore, shogaol decreased the expression level of antiapoptotic proteins (survivin and Bcl-2) and increased pro-apoptotic protein, Bax. Shogaol treatment induced apoptosis and a robust reduction in the levels of the antiapoptotic protein survivin but did not affect the levels of many other apoptosis regulators. Moreover, knockdown of survivin sensitized colon cancer cells to resistant of TRAIL-induced apoptosis. Therefore, we showed the functions of shogaol as a sensitizing agent to induce cell death of TRAIL-resistant colon cancer cells. This study gives rise to the possibility of applying shogaol as an antitumor agent that can be used for the purpose of combination treatment with TRAIL in TRAIL-resistant colon tumor therapy.

키워드

Shogaol; Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL); Apoptosis; Death receptor 5 (DR5); Survivin; PHASE-II TRIAL; GLIOBLASTOMA-MULTIFORME; RECURRENT GLIOBLASTOMA; ADJUVANT TEMOZOLOMIDE; MALIGNANT GLIOMA; APOPTOSIS; INDUCTION; RADIOTHERAPY; APO2L/TRAIL; CONCOMITANT
제목
Shogaol overcomes TRAIL resistance in colon cancer cells via inhibiting of survivin
저자
Hwang, Jung Soon; Lee, Hai-Chon; Oh, Sang Cheul; Lee, Dae-Hee; Kwon, Ki Han
DOI
10.1007/s13277-015-3629-2
발행일
2015-11
유형
Article
저널명
Tumor Biology
권
36
호
11
페이지
8819 ~ 8829